Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$138.04

-0.06 (-0.04%)

09:49
05/22/19
05/22
09:49
05/22/19
09:49

J&J's Janssen announces FDA priority review for Invokana

Johnson & Johnson's Janssen Pharmaceutical announced that the FDA has granted priority review for the supplemental new drug application for Invokana to reduce the risk of end-stage kidney disease, the doubling of serum creatinine, and renal or cardiovascular death in adults with type 2 diabetes and chronic kidney disease. If approved for the new indication, Invokana will be the first and only diabetes medicine to treat chronic kidney disease in patients with type 2 diabetes, Janssen said.

  • 16

    Jul

JNJ Johnson & Johnson
$138.04

-0.06 (-0.04%)

05/16/19
MSCO
05/16/19
NO CHANGE
MSCO
Equal Weight
Consensus J&J estimates likely to move higher after meeting, says Morgan Stanley
Morgan Stanley analyst David Lewis says the team at Johnson & Johnson expressed confidence in acceleration in the company's pharmaceuticals segment in 2020 and above-market growth through 2023, leading him to expect consensus pharma estimates are likely to move higher following the analyst day meeting. Lewis models pharma growth of about 7% in 2020, noting expected indication expansions in its current blockbuster franchises and the fact that pipeline contributions will increase. While he thinks "the J&J story looks brighter" as pharmaceuticals accelerate into 2020, Lewis keeps an Equal Weight rating on the shares.
05/06/19
WELS
05/06/19
NO CHANGE
Target $157
WELS
Outperform
Johnson & Johnson price target raised to $157 from $152 at Wells Fargo
Wells Fargo analyst Larry Biegelsen raised his price target for Johnson & Johnson to $157 from $152 ahead of its bi-annual Pharma investor day on May 15th. The analyst expects the company to highlight a robust in-market portfolio and late-stage pipeline that should help return the Pharmaceuticals business to above-market growth in 2020. While Pharma sales growth is expected to trail the market in 2019 due to the impact of generic Zytiga and Tracleer, and biosimilar erosion, continued growth of key franchises and increasing contribution from new products should deliver mid- to high-single digit Pharma sales growth in the coming years, he contends. Biegelsen reiterates an Outperform rating on the shares.
04/17/19
SPHN
04/17/19
NO CHANGE
SPHN
Issues facing healthcare sector now 'modest' compared to 2008-10, says Stephens
Stephens analyst Scott Fidel noted that the managed care group has sharply underperformed the S&P 500 over the last month amid "political rhetoric" around point-of-sale drug rebates and Medicare for all policy proposals, though he believes the issues facing the sector right now "seem modest in comparison" to the "dark days of 2008-2010." While recent Medicare for all proposals have rattled investors, "they will face enormous uphill battles," Fidel tells investors. Hospital stocks have outperformed MCOs year-to-date, but the group declined about 9% yesterday and underperformed the MCO group, which Fidel attributes to acknowledgement by industry bellwether UnitedHealth (UNH) of the significant disruptive nature of Medicare for all, which may have sparked additional fears, as well as one less calendar day being called out by UnitedHealth as benefiting Q1 MLRs and Johnson & Johnson's (JNJ) earnings call commentary on declining sequential hospital admissions from Q4. Publicly traded companies in the hospital space include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS). Publicly traded companies in the managed care space include Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
04/09/19
PIPR
04/09/19
NO CHANGE
Target $32
PIPR
Neutral
Alkermes' ALPINE data an incremental positive, says Piper Jaffray
After Alkermes (ALKS) reported this morning that its ALPINE trial met its primary endpoint and that Aristada showed similar efficacy to the current market leader, Invega Sustenna, at all time points assessed, Piper Jaffray analyst Danielle Brill said she views the data as an incremental positive. However, she thinks it will be challenging to capture share from Johnson & Johnson (JNJ), telling investors that she is "not sure these data will be enough to move the needle." Brill maintains a Neutral rating on Alkermes.

TODAY'S FREE FLY STORIES

RNST

Renasant

$34.10

-0.49 (-1.42%)

17:04
07/22/19
07/22
17:04
07/22/19
17:04
Earnings
Renasant reports Q2 EPS 80c with items, consensus 81c »

Reports Q2 net loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

17:03
07/22/19
07/22
17:03
07/22/19
17:03
Hot Stocks
Steel Dynamics announces planned new flat roll steel mill site selection »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Brown & Brown reports Q2 organic revenue up 3.9% »

Reports Q2 EBITDA margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

HAE

Haemonetics

$122.44

0.35 (0.29%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Haemonetics updates financial reporting segments »

Haemonetics Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

  • 05

    Sep

  • 09

    Sep

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:01
07/22/19
07/22
17:01
07/22/19
17:01
Earnings
Brown & Brown reports Q2 adjusted EPS 32c, consensus 28c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

DLX

Deluxe

$41.95

0.41 (0.99%)

17:00
07/22/19
07/22
17:00
07/22/19
17:00
Hot Stocks
Deluxe names Chris Thomas chief revenue officer »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 19

    Sep

GE

General Electric

$10.22

0.18 (1.79%)

, AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

16:57
07/22/19
07/22
16:57
07/22/19
16:57
Hot Stocks
Avalon GloboCare and GE Healthcare announce strategic partnership »

Avalon GloboCare (AVCO)…

GE

General Electric

$10.22

0.18 (1.79%)

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

  • 09

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

16:55
07/22/19
07/22
16:55
07/22/19
16:55
Hot Stocks
Breaking Hot Stocks news story on Viveve 

Viveve trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFF

Village Farms

$10.69

0.48 (4.70%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Initiation
Village Farms initiated  »

Village Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$75.72

0.995 (1.33%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Hot Stocks
Best Buy beneficial owner Richard Schulze sells $32.4M in company shares »

Best Buy beneficial owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

ORGO

Organogenesis

$5.85

-0.27 (-4.41%)

16:50
07/22/19
07/22
16:50
07/22/19
16:50
Syndicate
Organogenesis commences exchange offer »

Organogenesis Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

WD

Walker & Dunlop

$55.46

-0.39 (-0.70%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Hot Stocks
Walker & Dunlop appoints Chief Production Officer to Lead FHA finance team »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 15

    Aug

EQBK

Equity Bancshares

$24.43

-0.19 (-0.77%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Earnings
Equity Bancshares reports Q2 EPS 58c, consensus 60c »

The net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

RPAY

Repay Holdings

$11.51

-0.26 (-2.21%)

16:47
07/22/19
07/22
16:47
07/22/19
16:47
Hot Stocks
Monroe Capital reports 6.5% passive stake in Repay Holdings »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

TRWH

Twin River Worldwide

$28.10

0.1 (0.36%)

16:45
07/22/19
07/22
16:45
07/22/19
16:45
Hot Stocks
Twin River Worldwide extends tender offer expiration time to July 26 »

Twin River Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRWH

Twin River Worldwide

$28.10

0.1 (0.36%)

16:44
07/22/19
07/22
16:44
07/22/19
16:44
Earnings
Twin River Worldwide reports preliminary Q2 revenue $146.5M-$148.5M »

Consensus $161.33M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$137.84

0.55 (0.40%)

, MU

Micron

$47.21

1.7 (3.74%)

16:43
07/22/19
07/22
16:43
07/22/19
16:43
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks rose as earnings…

EFX

Equifax

$137.84

0.55 (0.40%)

MU

Micron

$47.21

1.7 (3.74%)

MTN

Vail Resorts

$235.48

9.665 (4.28%)

SKIS

Peak Resorts

$10.85

5.71 (111.09%)

FB

Facebook

$202.32

3.94 (1.99%)

INTC

Intel

$51.36

1.1 (2.19%)

AVGO

Broadcom

$296.11

6.06 (2.09%)

GOOG

Alphabet

$1,138.09

8.09 (0.72%)

GOOGL

Alphabet Class A

$1,139.52

7.85 (0.69%)

BX

Blackstone

$47.81

2.18 (4.78%)

CQP

Cheniere Energy Partners

$43.96

0.835 (1.94%)

BYND

Beyond Meat

$193.91

17.26 (9.77%)

HAL

Halliburton

$23.76

2.02 (9.29%)

PAYS

Paysign

$13.68

-3.81 (-21.78%)

CADE

Cadence Bancorp

$15.86

-3.75 (-19.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 12

    Aug

  • 26

    Aug

  • 27

    Aug

  • 23

    Sep

  • 26

    Sep

  • 27

    Oct

  • 13

    Nov

ACAD

Acadia

$25.97

0.28 (1.09%)

16:36
07/22/19
07/22
16:36
07/22/19
16:36
Hot Stocks
Breaking Hot Stocks news story on Acadia »

Acadia down over 16% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

ACAD

Acadia

$25.97

0.28 (1.09%)

16:35
07/22/19
07/22
16:35
07/22/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Acadia 

Acadia trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

FULC

Fulcrum Therapeutics

$12.84

0.35 (2.80%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Hot Stocks
Fulcrum Therapeutics chairman Mark Levin buys $1.3M in company shares »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$105.66

-1.35 (-1.26%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Earnings
Celanese still sees 'path to' FY19 EPS of $10.50, consensus $10.20 »

CEO Lori Ryerkerk says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FTI

TechnipFMC

$25.61

0.5 (1.99%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
TechnipFMC awarded iEPCI contract from Neptune Energy for Seagull project »

TechnipFMC has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

CE

Celanese

$105.66

-1.35 (-1.26%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
Celanese reports Q2 operating EBITDA $458M vs. $573M last year »

Reports Q2 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CTST

CannTrust

$2.73

-0.04 (-1.44%)

16:32
07/22/19
07/22
16:32
07/22/19
16:32
Hot Stocks
CannTrust agrees to waive exclusivity provision under agreement with Kindred »

CannTrust Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

, GE

General Electric

$10.22

0.18 (1.79%)

16:31
07/22/19
07/22
16:31
07/22/19
16:31
Hot Stocks
Avalon GloboCare, GE Healthcare announce strategic partnership »

Avalon GloboCare (AVCO)…

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

GE

General Electric

$10.22

0.18 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.